Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 53.91B | 55.31B | 51.96B | 49.89B | 44.76B | 37.61B |
Gross Profit | 9.18B | 9.46B | 9.12B | 9.16B | 8.37B | 6.86B |
EBITDA | 1.15B | 4.36B | 1.17B | 1.35B | 957.00M | 296.01M |
Net Income | 2.83B | 2.99B | 810.00M | 905.00M | 723.00M | 109.00M |
Balance Sheet | ||||||
Total Assets | 31.76B | 32.76B | 29.54B | 28.86B | 25.31B | 23.00B |
Cash, Cash Equivalents and Short-Term Investments | 12.30B | 9.08B | 6.31B | 6.23B | 5.17B | 5.14B |
Total Debt | 99.00M | 47.00M | 241.00M | 325.00M | 531.00M | 738.00M |
Total Liabilities | 17.59B | 18.20B | 16.23B | 15.93B | 14.12B | 13.08B |
Stockholders Equity | 14.17B | 14.55B | 13.30B | 12.93B | 11.19B | 9.92B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 2.00B | 555.00M | 1.38B | 313.00M | 1.09B |
Operating Cash Flow | 0.00 | 2.05B | 684.00M | 1.47B | 437.00M | 1.24B |
Investing Cash Flow | 0.00 | 890.00M | -332.00M | -86.00M | -137.00M | -138.00M |
Financing Cash Flow | 0.00 | -383.00M | -277.00M | -336.00M | -281.00M | 558.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
73 Outperform | ¥12.70B | 10.91 | 2.64% | 7.79% | 22.67% | ||
73 Outperform | ¥8.05B | 2.69 | 1.95% | 6.45% | 269.38% | ||
72 Outperform | ¥9.29B | 10.34 | 3.77% | 9.49% | -3.05% | ||
70 Outperform | ¥4.01B | 10.67 | 4.84% | 15.88% | 115.04% | ||
66 Neutral | £1.86B | 11.27 | 6.18% | 3.11% | 0.61% | -17.57% |